XML 34 R20.htm IDEA: XBRL DOCUMENT
v3.23.2

STOCK COMPENSATION PLANS | 6 Months Ended
--- | ---
Jul. 02, 2023
Share-Based Payment Arrangement [Abstract] |
Stock Compensation Plans | STOCK COMPENSATION PLANS Share-based grants for compensation and incentive purposes are made pursuant to the Equity and Incentive Compensation Plan (“EICP”). The EICP provides for grants of one or more of the following stock-based compensation awards to employees, non-employee directors and certain service providers upon whom the successful conduct of our business is dependent: •Non-qualified stock options (“stock options”); •Performance stock units (“PSUs”) and performance stock; •Stock appreciation rights; •Restricted stock units (“RSUs”) and restricted stock; and •Other stock-based awards. The EICP also provides for the deferral of stock-based compensation awards by participants if approved by the Compensation and Human Capital Committee of our Board and if in accordance with an applicable deferred compensation plan of the Company. Currently, the Compensation and Human Capital Committee has authorized the deferral of PSU and RSU awards by certain eligible employees under the Company’s Deferred Compensation Plan. Our Board has authorized our non-employee directors to defer any portion of their cash retainer, committee chair fees and RSUs awarded that they elect to convert into deferred stock units under our Directors’ Compensation Plan. At the time stock options are exercised or PSUs and RSUs become payable, Common Stock is issued from our accumulated treasury shares. Dividend equivalents are credited on RSUs on the same date and at the same rate as dividends paid on our Common Stock. Dividend equivalents are charged to retained earnings and included in accrued liabilities until paid. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. In addition, historical data is used to estimate forfeiture rates and record share-based compensation expense only for those awards that are expected to vest. For the periods presented, compensation expense for all types of stock-based compensation programs and the related income tax benefit recognized were as follows:
|  | Three Months Ended |  | Six Months Ended
|  | July 2, 2023 |  | July 3, 2022 |  | July 2, 2023 |  | July 3, 2022
Pre-tax compensation expense |  | $ | 16,848 |  |  | $ | 17,224 |  |  | $ | 35,840 |  |  | $ | 32,561 |
Related income tax benefit |  | 1,978 |  |  | 3,684 |  |  | 6,308 |  |  | 6,935 |
Compensation expenses for stock compensation plans are primarily included in SM&A expense. As of July 2, 2023, total stock-based compensation expense related to non-vested awards not yet recognized was $115,592 and the weighted-average period over which this amount is expected to be recognized was approximately 2.0 years. Stock Options The exercise price of each stock option awarded under the EICP equals the closing price of our Common Stock on the New York Stock Exchange on the date of grant. Each stock option has a maximum term of 10 years. Grants of stock options provide for pro-rated vesting, typically over a four-year period. Expense for stock options is based on grant date fair value and recognized on a straight-line method over the vesting period, net of estimated forfeitures. A summary of activity relating to grants of stock options for the period ended July 2, 2023 is as follows:
Stock Options | Shares | Weighted-Average Exercise Price (per share) | Weighted-Average Remaining Contractual Term | Aggregate Intrinsic Value
Outstanding at beginning of year | 976,634 |  | $104.36 | 3.8 years |
Granted | 5,215 |  | $240.90 |  |
Exercised | (216,977) |  | $102.93 |  |
Outstanding as of July 2, 2023 | 764,872 |  | $105.69 | 3.7 years | $ | 110,146 |
Options exercisable as of July 2, 2023 | 738,817 |  | $103.28 | 3.6 years | $ | 108,179 |
The weighted-average fair value of options granted was $57.65 and $37.28 per share for the periods ended July 2, 2023 and July 3, 2022, respectively. The fair value was estimated on the date of grant using a Black-Scholes option-pricing model and the following weighted-average assumptions:
|  | Six Months Ended
|  | July 2, 2023 |  | July 3, 2022
Dividend yields |  | 1.7 | % |  | 1.9 | %
Expected volatility |  | 20.9 | % |  | 21.1 | %
Risk-free interest rates |  | 4.1 | % |  | 1.9 | %
Expected term in years |  | 6.3 |  | 6.3
The total intrinsic value of options exercised was $31,581 and $24,870 for the periods ended July 2, 2023 and July 3, 2022, respectively. Performance Stock Units and Restricted Stock Units Under the EICP, we grant PSUs to select executives and other key employees. Vesting is contingent upon the achievement of certain performance objectives. We grant PSUs over three-year performance cycles. If we meet targets for financial measures at the end of the applicable three-year performance cycle, we award a resulting number of shares of our Common Stock to the participants. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of these performance metrics in accordance with the terms established at the time of the award. For PSUs granted, the target award is a combination of a market-based total shareholder return and performance-based components. For market-based condition components, market volatility and other factors are taken into consideration in determining the grant date fair value and the related compensation expense is recognized regardless of whether the market condition is satisfied, provided that the requisite service has been provided. For performance-based condition components, we estimate the probability that the performance conditions will be achieved each quarter and adjust compensation expenses accordingly. The performance scores of PSU grants during the six months ended July 2, 2023 and July 3, 2022 can range from 0% to 250% of the targeted amounts. We recognize the compensation expenses associated with PSUs ratably over the three-year term. Compensation expenses are based on the grant date fair value because the grants can only be settled in shares of our Common Stock. The grant date fair value of PSUs is determined based on the Monte Carlo simulation model for the market-based total shareholder return component and the closing market price of the Company’s Common Stock on the date of grant for performance-based components. During the six months ended July 2, 2023 and July 3, 2022, we awarded RSUs to certain executive officers and other key employees under the EICP. We also awarded RSUs to non-employee directors. We recognize the compensation expenses associated with employee RSUs over a specified award vesting period based on the grant date fair value of our Common Stock. We recognize expense for employee RSUs based on the straight- line method. The compensation expenses associated with non-employee director RSUs is recognized ratably over the vesting period, net of estimated forfeitures. A summary of activity relating to grants of PSUs and RSUs for the period ended July 2, 2023 is as follows:
Performance Stock Units and Restricted Stock Units |  | Number of units |  | Weighted-average grant date fair value for equity awards (per unit)
Outstanding at beginning of year |  | 1,141,679 |  |  | $181.91
Granted |  | 286,363 |  |  | $249.97
Performance assumption change (1) |  | 90,139 |  |  | $303.24
Vested |  | (418,071) |  |  | $172.11
Forfeited |  | (15,070) |  |  | $203.38
Outstanding as of July 2, 2023 |  | 1,085,040 |  |  | $213.43
(1)Reflects the net number of PSUs above and below target levels based on the performance metrics. The following table sets forth information about the fair value of the PSUs and RSUs granted for potential future distribution to employees and non-employee directors. In addition, the table provides assumptions used to determine the fair value of the market-based total shareholder return component using the Monte Carlo simulation model on the date of grant.
|  | Six Months Ended
|  | July 2, 2023 |  | July 3, 2022
Units granted |  | 286,363 |  | 294,729
Weighted-average fair value at date of grant |  | $ | 249.97 |  | $ | 210.80
Monte Carlo simulation assumptions: |  |  |  |
Estimated values |  | $ | 118.90 |  | $ | 100.41
Dividend yields |  | 1.7 | % |  | 1.8 | %
Expected volatility |  | 19.2 | % |  | 25.3 | %
The fair value of shares vested totaled $100,915 and $100,292 for the periods ended July 2, 2023 and July 3, 2022, respectively. Deferred PSUs, deferred RSUs and deferred stock units representing directors’ fees totaled 275,043 units as of July 2, 2023. Each unit is equivalent to one share of the Company’s Common Stock.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration